文献速递腹部泌尿生殖技术与安全CTMR

住院患者行碘对比剂与钆对比剂增强影像后急性肾衰竭风险可忽略

Negligible Risk of Acute Renal Failure Among Hospitalized Patients After Contrast-Enhanced Imaging With Iodinated Versus Gadolinium-Based Agents.
PubMed 文献 · Invest Radiol · 2019-01-01

该回顾性研究对比了12,580例接受碘对比剂增强CT与754例接受钆对比剂增强MRI的住院患者,经倾向性匹配后碘对比剂组急性肾损伤(AKI)发生率为7%,与钆对比剂组7.3%相比无显著差异(P=0.9)。但在碘对比剂组中,收缩压低于110 mmHg与AKI风险升高相关(OR 1.49,95%CI 1.16-1.88),而钆对比剂组无此关联。

要点

  • 住院患者行碘对比剂增强CT后AKI风险与钆对比剂增强MRI无显著差异(匹配后7% vs 7.3%,P=0.9)。
  • 碘对比剂组收缩压<110 mmHg时AKI风险升高(OR 1.49,95%CI 1.16-1.88),钆对比剂组无此关联。
  • 慢性肾衰竭、糖尿病、高龄、高血压等亚组中,碘对比剂与钆对比剂的AKI风险同样无显著差异。

核心结论

  • 在当前预防措施下,住院患者接受碘对比剂增强CT后发生对比剂后急性肾损伤(PC-AKI)的真实风险可忽略,与钆对比剂增强MRI相比无显著差异。

研究设计与样本

  • 回顾性评估,纳入12,580例接受碘对比剂增强CT的住院患者与754例接受钆对比剂增强MRI的住院患者,并进行倾向性匹配以校正临床特征和潜在危险因素。

诊断标准与关键数值

  • 倾向性匹配前碘对比剂组AKI发生率为8%,钆对比剂组为7.3%(P=0.3);匹配后碘对比剂组AKI发生率为7%(P=0.9)。收缩压低于110 mmHg时,碘对比剂组AKI的OR为1.49(95%CI 1.16-1.88),钆对比剂组OR为0.12(95%CI 0.003-0.73)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: The potential adverse renal outcome among patients undergoing iodine-based contrast-enhanced computerized tomography (CT) has been questioned recently, given the caution undertaken in patients' selection, hydration protocols, and the low radiocontrast volume, used with advanced imaging equipment.

MATERIALS AND METHODS: This study is a retrospective assessment of renal outcome in 12,580 hospitalized patients undergoing contrast-enhanced CT, compared with 754 patients subjected to gadolinium-based magnetic resonance imaging, with subsequent propensity matching for clinical characteristics and potential risk factors.

RESULTS: The risk of postcontrast acute kidney injury (PC-AKI) was found to be negligible as compared with patients undergoing enhanced magnetic resonance imaging studies, before and after propensity matching (8% vs 7.3% rate of AKI in the nonmatched iodine-based contrast agents [IBCAs] and gadolinium-based contrast agents [GBCAs], respectively, P = 0.3, and 7% in the matched IBCA group, P = 0.9), including comparisons among subgroups with well-defined risk factors such as chronic renal failure, diabetes, older age, and hypertension. However, lower systolic blood pressure before imaging was associated with higher risk to develop PC-AKI after IBCA administration but not with GBCA (for systolic blood pressure lower than 110 mm Hg, odds ratio for AKI after IBCA was 1.49; 95% confidence interval, 1.16-1.88, and after GBCA; odds ratio, 0.12; 95% confidence interval, 0.003-0.73).

CONCLUSIONS: With the current precautions undertaken, the real-life risk of PC-AKI among inpatients undergoing CT is insignificant. Possible reasons for the diverse impact of blood pressure on the propensity to develop acute kidney failure after iodine-based but not gadolinium-based enhancement imaging are discussed.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Gorelik Y, Yaseen H, Heyman SN, et al. Negligible Risk of Acute Renal Failure Among Hospitalized Patients After Contrast-Enhanced Imaging With Iodinated Versus Gadolinium-Based Agents. Invest Radiol. 2019. PMID: 30480553. doi:10.1097/RLI.0000000000000534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。